Alexander Mackenzie

Track

Insider profile

Currently holds a position at Pfizer Inc

Performance

Overall performance

2.2

Performance over holding periods

2.2

	30 days	90 days	120 days
Average return	-4%	8.2%	15.1%
Success rate	0%	68%	82%
Transactions	1 0% Buy	34 71% Buy	47 69% Buy

Ranking by holding-period performance

Positions

Position	Company	Period
Executive Vice President, Chief Development Officer	Pfizer Inc	June 1, 2016 -

Other insiders

Pfizer Inc

Sally Susman READ IAN C Mikael Dolsten Doug Lankler DAMELIO FRANK A

Pfizer Inc

Alexander Mackenzie's trades of Pfizer Inc's stock

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2021-12-06	2021-12-02	Pfizer Inc (PFE)	S Sale	33,277 +20.6% 320.43 US$1,884,572	33,277 +20.6%	320.43	US$1,884,572
2019-06-21	2019-06-20	Pfizer Inc (PFE)	PlS Planned sale	79,440 +4.9% 320.88 US$2,046,234	79,440 +4.9%	320.88	US$2,046,234
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	50,918 +1.6% 201.08 US$3,562,445	50,918 +1.6%	201.08	US$3,562,445
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	1,581 -1.4% 42.90 US$67,825	1,581 -1.4%	42.90	US$67,825
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	1,230 -1.1% 42.80 US$52,644	1,230 -1.1%	42.80	US$52,644
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	1,134 -1.0% 42.85 US$48,592	1,134 -1.0%	42.85	US$48,592
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	1,100 -0.9% 42.82 US$47,102	1,100 -0.9%	42.82	US$47,102
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	800 -0.7% 42.79 US$34,232	800 -0.7%	42.79	US$34,232
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	713 -0.6% 42.84 US$30,545	713 -0.6%	42.84	US$30,545
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	703 -0.6% 42.81 US$30,095	703 -0.6%	42.81	US$30,095
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	658 -0.5% 42.83 US$28,182	658 -0.5%	42.83	US$28,182
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	623 -0.5% 42.91 US$26,733	623 -0.5%	42.91	US$26,733
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	600 -0.5% 42.76 US$25,656	600 -0.5%	42.76	US$25,656
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	600 -0.5% 42.77 US$25,662	600 -0.5%	42.77	US$25,662
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	560 -0.5% 42.89 US$24,018	560 -0.5%	42.89	US$24,018
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	555 -0.5% 42.87 US$23,793	555 -0.5%	42.87	US$23,793
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	547 -0.4% 42.86 US$23,444	547 -0.4%	42.86	US$23,444
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	300 -0.2% 42.78 US$12,834	300 -0.2%	42.78	US$12,834
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	294 -0.2% 42.67 US$12,545	294 -0.2%	42.67	US$12,545
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	200 -0.2% 42.59 US$8,518	200 -0.2%	42.59	US$8,518
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	152 -0.1% 42.92 US$6,524	152 -0.1%	42.92	US$6,524
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	128 -0.1% 42.60 US$5,453	128 -0.1%	42.60	US$5,453
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	107 -0.1% 42.61 US$4,559	107 -0.1%	42.61	US$4,559
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	100 -0.1% 42.74 US$4,274	100 -0.1%	42.74	US$4,274
2019-04-02	2019-04-01	Pfizer Inc (PFE)	PlS Planned sale	100 -0.1% 42.93 US$4,293	100 -0.1%	42.93	US$4,293